Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT06033378
Recruiting Not applicable

Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage.

NCT06033378 · tracked via the Priya Life Science Sweden tracker
Sponsor
Umeå University
Phase
Not applicable
Started
2023-09-01
Last updated
2025-03-13

Condition(s) studied

Blood PressureSubarachnoid HemorrhageAneurysm Cerebral

Investigational drug(s) / intervention(s)

Blood pressure elevation

Blood pressure elevation: Increasing systemic blood pressure for measurement of cerebral blood flow changes

Study summary

An MRI study to examine the relationship between blood pressure and cerebral blood flow in patients with subarachnoidal hemorrhage and suspect or verified vasospasm.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Coiled or clipped aneurysm * Suspected or confirmed vasospasm Exclusion Criteria: * BMI \>30 * Pregnancy * Pacemaker or other MRI contraindications * Severe congestive heart failure (NYHA III-IV) or cardiac arrhythmia. * Severe respiratory failure or FiO2 \>0.6 * Severe kidney failure

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Umeå University Hospital Umeå Sweden Recruiting

More Umeå University trials in Sweden

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer Recruiting
Dual vs. Single-Antibiotic Impregnated Cement in Hemiarthroplasty for Femoral Neck Fracture Active, not recruiting
Heparin-binding Protein and Lungedema in ICU Patients. Recruiting
Single-Stapled Technique for Colorectal Anastomosis Recruiting
Prognostic Factors in Periampullary Tumors and Cysts Recruiting

Other trials for the same condition

Remote Investigation and Assessment of Vital Signs Recruiting
MRI Assesment of Cerebral Blood Flow in Anesthetized Children Starting soon
Hypertension and Cerebrovascular Hemodynamics in General Anaesthesia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06033378 on ClinicalTrials.gov ↗ ← All trials in Sweden